Stryker Corporation

SYK Healthcare Medical Devices

Stryker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $25.1 billion, up 11.2% from fiscal 2024.

Revenue
+7.64%
EPS
−12.4%
Free cash flow
−19.4%
Total debt
−10.0%

Quarter to September 2026, against a year earlier

324.26 10.82 −3.23%
Market cap
$127.6B
P/E
35.3×
Fwd P/E
24.6×
Dividend yield
1.05%
F-score
5/9
Altman Z
4.81
Beneish M
−2.62
Dividend safety
82/100
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
41.40 45.87 35.52 39.49 50.55 57.39 37.69 16.52 57.84 27.08
Piotroski F-Score
5 6 7 6 8 3 5 3 5 7
P/S ratio
5.35 6.07 5.49 5.04 5.89 6.41 5.28 4.31 4.75 3.95
Altman Z-Score
4.81 5.30 4.76 4.18 4.54 3.90 4.31 3.85 4.56 4.26
Altman Z″-Score (non-manufacturers)
3.96 4.06 3.70 3.39 3.60 3.16 4.10 3.90 4.21 4.56
P/FCF ratio
31.36 39.34 35.86 45.70 36.82 32.98 50.92 28.77 61.45 31.35
Beneish M-Score
(2.62) (2.57) (2.50) (2.32) (2.54) (2.72) (2.28) (2.28) (2.45) (2.34)
P/Operating CF
62.68 71.04 73.59 92.77 100.82 74.38 106.83 56.06 86.97 67.90
Dividend Safety Score
82 — — — — — — — — —
P/B ratio
5.99 6.65 6.05 5.60 6.78 7.03 6.13 5.00 5.92 4.68
EV/Sales
5.82 6.47 5.97 5.65 6.45 7.18 5.72 4.76 5.10 4.26
EV/EBITDA
24.02 30.87 24.90 27.13 30.86 33.93 24.40 19.88 21.60 17.72
EV/FCF
34.11 41.95 39.03 51.16 40.28 36.91 55.24 31.80 66.06 33.83
Current Ratio
1.89 1.95 1.58 1.63 2.20 1.93 2.51 2.02 2.29 2.50
Net Debt/EBITDA
1.93 1.92 2.02 2.90 2.65 3.61 1.91 1.89 1.51 1.30
Debt/Equity
0.71 0.66 0.70 0.79 0.84 1.07 0.87 0.84 0.72 0.72
ROE
15.08% 15.26% 17.98% 14.97% 14.26% 12.35% 16.98% 32.73% 10.45% 18.24%
ROA
7.15% 7.22% 8.24% 6.59% 5.78% 4.96% 7.26% 14.38% 4.79% 8.99%
ROIC
8.94% 7.75% 8.52% 6.40% 6.64% 5.78% 8.71% 8.86% 9.96% 10.39%
Return on Tangible Assets
29.95% 28.03% 40.51% 33.97% 24.02% 21.56% 22.58% 49.23% 15.73% 26.22%
Average Days of Receivables
58.70 64.41 67.04 70.53 64.47 68.70 70.95 62.58 64.47 63.40
Earnings Yield
2.42% 2.18% 2.82% 2.53% 1.98% 1.74% 2.65% 6.05% 1.73% 3.69%
Free Cash Flow Yield
3.19% 2.54% 2.79% 2.19% 2.72% 3.03% 1.96% 3.48% 1.63% 3.19%
Free Cash Flow per Share
11.21 9.15 8.26 5.38 7.26 7.43 4.12 5.45 2.57 3.81
Book value per Share
58.66 54.16 48.98 43.93 39.46 34.84 34.24 31.36 26.68 25.53
Free Cash Flow
4,283.00 3,487.00 3,136.00 2,036.00 2,738.00 2,790.00 1,542.00 2,038.00 961.00 1,425.00
EV/EBIT
29.88 39.65 31.48 36.67 42.68 46.32 31.40 25.54 27.64 22.16
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026